CN103736068B - A kind of medicament for the treatment of pruritus vulvae - Google Patents
A kind of medicament for the treatment of pruritus vulvae Download PDFInfo
- Publication number
- CN103736068B CN103736068B CN201410026197.6A CN201410026197A CN103736068B CN 103736068 B CN103736068 B CN 103736068B CN 201410026197 A CN201410026197 A CN 201410026197A CN 103736068 B CN103736068 B CN 103736068B
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- radix
- pruritus vulvae
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of medicament for the treatment of pruritus vulvae, it is made up by weight of following bulk drugs: Yi Zhiqi, Chinese mugwort in thousand, Herba Caryopteridis Terniflorae, Flos seu Radix Impatientis nolitangeris, Ramulus Cinnamomi, Herba Blumeae clarkei, the Radix Paeoniae Alba, Pseudobulbus Coelogynes corymbosae, Radix Ophiopogonis, Folium Ligustri QuihouiCortex seu Folium Ligustri nitidi, the Radix Angelicae Dahuricae, thorn are blood red, Folium Mori, Rhizoma Tupistrae Chinensis, Poria, Herba Inulae cappae, Semen Coicis, Herba Elsholtziae Ciliatae and Rhizoma Zingiberis Recens.The medicament for the treatment of pruritus vulvae of the present invention has the effect of heat-clearing and toxic substances removing, cooling blood for hemostasis, loose addiction detumescence, effectively can treat pruritus vulvae.
Description
Technical field
The present invention relates to health check-up section field, relate in particular to a kind of medicament for the treatment of pruritus vulvae.
Background technology
Pruritus vulvae can occur separately, also can be the local symptom of multiple vulvovaginal illness and some systemic disease, as the Symptoms of vulvitis, vaginitis, vulval eczema, tinea corporis etc., can show as that pudendum normally also can show as erythema, pimple, sepage, chaps, lichenization etc., for the commonly encountered diseases of gynecological or department of dermatologry, there is touching not healing and relapse rate high, have a strong impact on physiology and the mental health of patient.
Summary of the invention
The object of this invention is to provide a kind of medicament for the treatment of pruritus vulvae.
In order to realize object of the present invention, the invention provides a kind of medicament for the treatment of pruritus vulvae, it is made up by weight of following bulk drugs: flag 10-30 part, Chinese mugwort 1-30 part in thousand, Herba Caryopteridis Terniflorae 1-20 part, Flos seu Radix Impatientis nolitangeris 1-20 part, Ramulus Cinnamomi 1-20 part, Herba Blumeae clarkei 1-20 part, Radix Paeoniae Alba 1-20 part, Pseudobulbus Coelogynes corymbosae 1-20 part, Radix Ophiopogonis 1-20 part, Folium Ligustri QuihouiCortex seu Folium Ligustri nitidi 1-20 part, Radix Angelicae Dahuricae 1-20 part, sting blood red 1-20 part, Folium Mori 1-10 part, Rhizoma Tupistrae Chinensis 1-10 part, Poria 1-10 part, Herba Inulae cappae 1-10 part, Semen Coicis 1-10 part, Herba Elsholtziae Ciliatae 1-10 part and Rhizoma Zingiberis Recens 1-10 part.
Preferably, the medicament for the treatment of pruritus vulvae of the present invention is made up by weight of following bulk drugs: flag 10-20 part, Chinese mugwort 5-20 part in thousand, Herba Caryopteridis Terniflorae 5-10 part, Flos seu Radix Impatientis nolitangeris 5-15 part, Ramulus Cinnamomi 5-15 part, Herba Blumeae clarkei 5-15 part, Radix Paeoniae Alba 1-10 part, Pseudobulbus Coelogynes corymbosae 1-10 part, Radix Ophiopogonis 1-10 part, Folium Ligustri QuihouiCortex seu Folium Ligustri nitidi 1-10 part, Radix Angelicae Dahuricae 1-10 part, sting blood red 1-10 part, Folium Mori 1-5 part, Rhizoma Tupistrae Chinensis 1-5 part, Poria 1-5 part, Herba Inulae cappae 1-5 part, Semen Coicis 1-5 part, Herba Elsholtziae Ciliatae 1-5 part and Rhizoma Zingiberis Recens 1-5 part.
More preferably, the medicament for the treatment of pruritus vulvae of the present invention is made up by weight of following bulk drugs: flag 15 parts, thousand Chinese mugworts 10 parts, Herba Caryopteridis Terniflorae 8 parts, Flos seu Radix Impatientis nolitangeris 9 parts, Ramulus Cinnamomi 8 parts, Herba Blumeae clarkei 6 parts, the Radix Paeoniae Alba 5 parts, Pseudobulbus Coelogynes corymbosae 6 parts, Radix Ophiopogonis 5 parts, Folium Ligustri QuihouiCortex seu Folium Ligustri nitidi 6 parts, the Radix Angelicae Dahuricae 5 parts, sting blood red 5 parts, 3 parts, Folium Mori, Rhizoma Tupistrae Chinensis 3 parts, 3 parts, Poria, Herba Inulae cappae 3 parts, Semen Coicis 3 parts, Herba Elsholtziae Ciliatae 3 parts and 2 parts, Rhizoma Zingiberis Recens.
More preferably, described medicament can be tablet, dispersible tablet, disintegrating tablet, rapidly dissolving tablet, enteric coatel tablets, capsule or lotion.
In the present compositions, Yi Zhiqi, Chinese mugwort, Herba Caryopteridis Terniflorae, Flos seu Radix Impatientis nolitangeris in thousand are monarch drug; Ramulus Cinnamomi, Herba Blumeae clarkei, the Radix Paeoniae Alba, Pseudobulbus Coelogynes corymbosae, Radix Ophiopogonis, Folium Ligustri QuihouiCortex seu Folium Ligustri nitidi are ministerial drug; The Radix Angelicae Dahuricae, to sting blood red, Folium Mori, Rhizoma Tupistrae Chinensis be adjuvant drug; Poria, Herba Inulae cappae, Semen Coicis, Herba Elsholtziae Ciliatae and Rhizoma Zingiberis Recens are for making medicine, and various ingredient exerts synergism is to produce optimum efficiency.
In order to understand the present invention better, with reference to " Chinese medicine voluminous dictionary " second edition (Shanghai science tech publishing house, 2005), the explanation of some crude drug used in the present invention sees the following form:
The medicament for the treatment of pruritus vulvae of the present invention has the effect of heat-clearing and toxic substances removing, cooling blood for hemostasis, loose addiction detumescence, effectively can treat pruritus vulvae.
Detailed description of the invention
The present invention is further illustrated below by embodiment.It should be understood that embodiments of the invention are for illustration of the present invention instead of limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Unless otherwise stated, the percent in the present invention is percetage by weight.
Embodiment lotion of the present invention
Get 15 grams, a flag, Chinese mugwort in thousand 10 grams, Herba Caryopteridis Terniflorae 8 grams, Flos seu Radix Impatientis nolitangeris 9 grams, Ramulus Cinnamomi 8 grams, Herba Blumeae clarkei 6 grams, the Radix Paeoniae Alba 5 grams, Pseudobulbus Coelogynes corymbosae 6 grams, Radix Ophiopogonis 5 grams, Folium Ligustri QuihouiCortex seu Folium Ligustri nitidi 6 grams, the Radix Angelicae Dahuricae 5 grams, sting blood red 5 grams, 3 grams, Folium Mori, Rhizoma Tupistrae Chinensis 3 grams, 3 grams, Poria, Herba Inulae cappae 3 grams, Semen Coicis 3 grams, Herba Elsholtziae Ciliatae 3 grams and 2 grams, Rhizoma Zingiberis Recens, add 20000 milliliters, water, heat 6 hours at 90 DEG C in the flask that condenser is housed, filter, filtrate is lotion of the present invention.
Experimental example
Physical data
100 routine patients all carry out self-Out-patient Department, are simple pruritus vulvae patient.21 years old-64 years old age, average 36.3 years old; The course of disease 3 months-2a, average 12.4 months.Patient is divided into treatment group 50 example, matched group 50 example.Two groups in age, the course of disease, symptom through statistical procedures there was no significant difference (P>0.05), there is comparability.
Treatment group: use the lotion prepared in embodiment to treat.Use lotion to clean vulvar mucous membrane pruritus place, clean 3 every day, each use 500 milliliters cleaning 2 minutes.Continuous treatment 1 week.
Matched group adopts Pevisone (Xian-Janssen Pharmaceutical Ltd.) external 5 grams to be coated on vulvar mucous membrane pruritus place.Continuous treatment 1 week.
Criterion of therapeutical effect
Criterion of therapeutical effect is formulated with reference to State Administration of Traditional Chinese Medicine's " Chinese medical disease Standardization of diagnosis and curative effect ".Cure: skin lesion all disappears, clinical symptom disappearance; Effective: skin lesion disappears more than 30%; Invalid: skin lesion is not improved or disappears less than 30%.
Result
Through treatment, two groups the results are shown in following table.
| Group | Number of cases | Cure | Effectively | Invalid | Total effective rate (%) |
| Treatment group | 50 | 41 | 9 | 0 | 100 |
| Matched group | 50 | 15 | 20 | 15 | 70 |
Model case
Open ××, female, 38 years old, on February 12nd, 2013 goes to a doctor.Main suit: pruritus vulvae 1 year, recurrent exerbation.The violent pruritus of the recent pudendum of patient, goes to a doctor in Duo Jia hospital, once external multiple gynecological lotion (name is not quite clear) and dermatitis equality ointment, heavy time light time after treatment, never thoroughly cures.Training checks: the obvious flushing of vulvar mucous membrane is chapped, slight atrophy, and color and luster is deepened, and slight lichenization appears in partial skin position.Diagnosis: pruritus vulvae.The lotion prepared in embodiment is used to treat.Use lotion to clean vulvar mucous membrane pruritus place, clean 3 every day, each use 500 milliliters cleaning 2 minutes.Continuous treatment 1 week.Pruritus obviously alleviates, disappearance of chapping, and pudendum is normal, enjoins it to be careful in one's diet and the adjustment of operating pressure, follows up a case by regular visits to and do not recur for 1 year again.
Lee ×, female, 26 years old, on June 26th, 2013 went to a doctor.Main suit: pruritus vulvae half a year, recurrent exerbation.Patient is the violent pruritus of pudendum over nearly 1 month.Training checks: the obvious flushing of vulvar mucous membrane is chapped, slight atrophy, and color and luster is deepened, and slight lichenization appears in partial skin position.Diagnosis: pruritus vulvae.The lotion prepared in embodiment is used to treat.Use lotion to clean vulvar mucous membrane pruritus place, clean 3 every day, each use 500 milliliters cleaning 2 minutes.Continuous treatment 1 week.Pruritus obviously alleviates, disappearance of chapping, and pudendum is normal, enjoins it to be careful in one's diet and the adjustment of operating pressure, follows up a case by regular visits to and do not recur for 1 year again.
King ×, female, 49 years old, within 2013, JIUYUE was gone to a doctor on the 18th.Main suit: pruritus vulvae 1 year half, recurrent exerbation.The nearly violent pruritus of pudendum over the past half year of patient.Training checks: the obvious flushing of vulvar mucous membrane is chapped, slight atrophy, and color and luster is deepened, and slight lichenization appears in partial skin position.Diagnosis: pruritus vulvae.The lotion prepared in embodiment is used to treat.Use lotion to clean vulvar mucous membrane pruritus place, clean 3 every day, each use 500 milliliters cleaning 2 minutes.Continuous treatment 1 week.Pruritus obviously alleviates, disappearance of chapping, and pudendum is normal, enjoins it to be careful in one's diet and the adjustment of operating pressure, follows up a case by regular visits to and do not recur for 1 year again.
Claims (1)
1. treat the medicament of pruritus vulvae for one kind, it is characterized in that, it is made up by weight of following bulk drugs: flag 15 parts, thousand Chinese mugworts 10 parts, Herba Caryopteridis Terniflorae 8 parts, Flos seu Radix Impatientis nolitangeris 9 parts, Ramulus Cinnamomi 8 parts, Herba Blumeae clarkei 6 parts, the Radix Paeoniae Alba 5 parts, Pseudobulbus Coelogynes corymbosae 6 parts, Radix Ophiopogonis 5 parts, Folium Ligustri QuihouiCortex seu Folium Ligustri nitidi 6 parts, the Radix Angelicae Dahuricae 5 parts, sting blood red 5 parts, 3 parts, Folium Mori, Rhizoma Tupistrae Chinensis 3 parts, 3 parts, Poria, Herba Inulae cappae 3 parts, Semen Coicis 3 parts, Herba Elsholtziae Ciliatae 3 parts and 2 parts, Rhizoma Zingiberis Recens.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410026197.6A CN103736068B (en) | 2014-01-21 | 2014-01-21 | A kind of medicament for the treatment of pruritus vulvae |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410026197.6A CN103736068B (en) | 2014-01-21 | 2014-01-21 | A kind of medicament for the treatment of pruritus vulvae |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103736068A CN103736068A (en) | 2014-04-23 |
| CN103736068B true CN103736068B (en) | 2015-11-25 |
Family
ID=50493184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410026197.6A Expired - Fee Related CN103736068B (en) | 2014-01-21 | 2014-01-21 | A kind of medicament for the treatment of pruritus vulvae |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103736068B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3046541B1 (en) * | 2016-01-12 | 2018-02-09 | Societe Industrielle Limousine D'application Biologique | ACTIVE PRINCIPLE OBTAINED FROM OPHIOPOGON JAPONICUS FOR THE TREATMENT OF ATOPIC DERMATITIS |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1840169A (en) * | 2006-01-12 | 2006-10-04 | 魏敏政 | A Chinese medicinal composition and its application in relieving pain and skin itching |
| CN102846934A (en) * | 2011-06-30 | 2013-01-02 | 苏州知微堂生物科技有限公司 | Preparation technology and production method for an integrated new formulation of warming channel decoction |
| CN103071085A (en) * | 2013-01-14 | 2013-05-01 | 上海浦东高星生物技术研究所 | Chinese patent drug for curing pruritus vulvae of old women |
-
2014
- 2014-01-21 CN CN201410026197.6A patent/CN103736068B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1840169A (en) * | 2006-01-12 | 2006-10-04 | 魏敏政 | A Chinese medicinal composition and its application in relieving pain and skin itching |
| CN102846934A (en) * | 2011-06-30 | 2013-01-02 | 苏州知微堂生物科技有限公司 | Preparation technology and production method for an integrated new formulation of warming channel decoction |
| CN103071085A (en) * | 2013-01-14 | 2013-05-01 | 上海浦东高星生物技术研究所 | Chinese patent drug for curing pruritus vulvae of old women |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103736068A (en) | 2014-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102784232B (en) | Chinese medicine composition for treating viral influenza | |
| CN105079226A (en) | Application of traditional Chinese medicine composition to preparation of drug for resisting Middle East respiratory syndrome corona-virus (MERS-CoV) | |
| CN103301400B (en) | A kind of Chinese medicine composition and preparation method for the treatment of chronic atrophic gastritis | |
| CN105381132A (en) | Drug for treating thyroid nodule | |
| CN102552512B (en) | Traditional Chinese medicine used for treating hepatitis B | |
| CN102139051B (en) | Application of soft capsule capable of clearing heat and eliminating toxin in preparation of medicament for treating viral pneumonia | |
| CN103736068B (en) | A kind of medicament for the treatment of pruritus vulvae | |
| CN105194584A (en) | Medicine for treating dysmenorrhea | |
| CN104147194A (en) | Traditional Chinese medicine composition for treating chronic sinusitis | |
| CN104027514A (en) | Traditional Chinese medicine used for treating acute cholecystitis | |
| CN103721109B (en) | A kind of medicament for the treatment of chronic cholecystitis | |
| CN102824563B (en) | Method for preparing Chinese medicinal lotion for treating closed fracture due to frequent micturition and urgent micturition | |
| CN101502583A (en) | Chinese medicament preparation for treating cholecystitis and gall-stone as well as preparation method thereof | |
| CN104622995A (en) | Pharmaceutical composition for treating chronic superficial gastritis and preparation method of pharmaceutical composition | |
| CN105582187B (en) | A Chinese medicinal composition for preventing and treating allergic dermatoses | |
| CN104547851B (en) | One treats hypertensive medicine | |
| CN104127542A (en) | Pharmaceutical composition for treatment of pediatric recurrent upper respiratory tract infection | |
| CN104474184B (en) | A kind of drug for treating cough after common cold | |
| CN103446545A (en) | Traditional Chinese medicine composition for treating chronic atrophic gastritis and preparation method thereof | |
| CN103463401B (en) | Asthma medicine for infants | |
| CN102716371B (en) | Traditional Chinese medicine composition for curing chronic cough as well as preparation method and usages thereof | |
| CN102657836B (en) | Medicine composition used for treating insomnia | |
| CN101732469A (en) | Application of Chinese medicinal composition in preparation of medicament for treating aphonia | |
| CN103721108B (en) | A kind of medicament for the treatment of acute icterohepatitis | |
| CN108578549B (en) | Medicine for treating acne and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20151125 Termination date: 20170121 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |